Journal ArticleDOI
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity.
Ali Aminian,Stacy A. Brethauer,Amin Andalib,Amy S. Nowacki,Amanda Jiménez,Ricard Corcelles,Zubaidah Nor Hanipah,Suriya Punchai,Deepak L. Bhatt,Sangeeta R. Kashyap,Bartolome Burguera,Antonio M. Lacy,Josep Vidal,Philip R. Schauer +13 more
Reads0
Chats0
TLDR
This is the largest reported cohort with long-term postoperative glycemic follow-up, which categorizes T2DM into 3 validated severity stages for evidence-based procedure selection, and categorizes RYGB was significantly more effective than SG, likely related to its more pronounced neurohormonal effects.Abstract:
Objective:To construct and validate a scoring system for evidence-based selection of bariatric and metabolic surgery procedures according to severity of type 2 diabetes (T2DM).Background:Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) account for >95% of bariatric procedures in United Stread more
Citations
More filters
Journal ArticleDOI
Metabolic and bariatric surgery: diabetes - a decade of discovery
Eric Veilleux,Rami Lutfi +1 more
TL;DR: This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author and the source.
Prédiction à long terme de la rémission et de la rechute du diabète de type 2 après bypass Roux-en-Y : développement et validation d’un score prédictif, le 5y-Ad-DiaRem
TL;DR: Le 5y-Ad-DiaRem predit precisement la DR a 5 ans, and semble utile pour identifier les patients a risque de rechute, en limitant par exemple the reprise de poids.
Journal ArticleDOI
[Will laparoscopic sleeve gastrectomy continue to exist as a stand-alone procedure? : A procedure critical perspective].
TL;DR: Whether sleeve gastrectomy can still be considered a stand-alone procedure is critically discussed to ensure patients are informed of the procedure-specific risks, including the unforeseeable need for revision or redo surgery firstly due to weight regain or failing to reach the individual therapy target.
Journal ArticleDOI
Reference Values for Weight Loss During 1 Year After Sleeve Gastrectomy: a Multicenter Retrospective Study in Japan
Tsuyoshi Yamaguchi,Masaji Tani,Kazunori Kasama,Takeshi Naitoh,Takashi Oshiro,Kentaro Inoue,Yosuke Seki,Hirofumi Imoto,Sachiko Kaida,Jun Matsubayashi +9 more
TL;DR:
Journal ArticleDOI
Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery
Saptarshi Bhattacharya,Sanjay Kalra,Nitin Kapoor,Rajiv Singla,Deep Dutta,Sameer Aggarwal,Deepak Khandelwal,Vineet Surana,Atul Dhingra,Viny Kantroo,Sachin Chittawar,Nilakshi Deka,Vivek Bindal,Puja Dutta +13 more
TL;DR: In this paper, Laparoscopic Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) are the most commonly used bariatric procedures worldwide, but emerging evidence indicates that RYGB is more effective than LSG in improving glycemic control and induces higher rates of longterm DM remission.
References
More filters
Journal ArticleDOI
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Philip R. Schauer,Deepak L. Bhatt,John P. Kirwan,Kathy Wolski,Ali Aminian,Stacy A. Brethauer,Sankar D. Navaneethan,Rishi P. Singh,Claire E. Pothier,Steven E. Nissen,Sangeeta R. Kashyap +10 more
TL;DR: Five‐year outcome data showed that, among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective thanintensive medical therapy alone in decreasing, or in some cases resolving, hyperglycemia.
Journal ArticleDOI
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Philip R. Schauer,Deepak L. Bhatt,John P. Kirwan,Kathy Wolski,Stacy A. Brethauer,Sankar D. Navaneethan,Ali Aminian,Claire E. Pothier,Steven E. Nissen,Sangeeta R. Kashyap,Abstr Act +10 more
TL;DR: Among obese patients with uncontrolled type 2 diabetes, 3 years of intensive medical therapy plus bariatric surgery resulted in glycemic control in significantly more patients than did medical therapy alone.
Journal ArticleDOI
Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone,Geltrude Mingrone,Simona Panunzi,Andrea De Gaetano,Caterina Guidone,Amerigo Iaconelli,Giuseppe Nanni,Marco Castagneto,Stefan R. Bornstein,Francesco Rubino +9 more
TL;DR: Surgery is more effective than medical treatment for the long-term control of obese patients with type 2 diabetes and should be considered in the treatment algorithm of this disease, however, continued monitoring of glycaemic control is warranted because of potential relapse of hyperglycaemia.
Journal ArticleDOI
How Do We Define Cure of Diabetes
John B. Buse,Sonia Caprio,William T. Cefalu,Antonio Ceriello,Stefano Del Prato,Silvio E. Inzucchi,Sue McLaughlin,Gordon L. Phillips,R. Paul Robertson,Francesco Rubino,Richard Kahn,M. Sue Kirkman +11 more
TL;DR: A consensus group of experts comprised of experts in pediatric and adult endocrinology, diabetes education, transplantation, metabolism, bariatric/metabolic surgery, and (for another perspective) hematology-oncology met in June 2009 to discuss issues.
Journal ArticleDOI
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Francesco Rubino,David M. Nathan,Robert H. Eckel,Philip R. Schauer,K. George M.M. Alberti,Paul Zimmet,Stefano Del Prato,Linong Ji,Shaukat Sadikot,William H. Herman,Stephanie A. Amiel,Lee M. Kaplan,Gaspar Taroncher-Oldenburg,David E. Cummings +13 more
TL;DR: Although additional studies are needed to further demonstrate long-term benefits, there is sufficient clinical and mechanistic evidence to support inclusion of metabolic surgery among antidiabetes interventions for people with T2D and obesity.